tirzepatide triple agonist Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review Retatrutide vs Tirzepatide (Research Comparison)

21,22 Therapeutic uses of glutathione in various diseases are being explored and it is possible that we will see establishment of a clear role for glutathione in the management of various conditions

That said, people dont always talk about the downstream consequences of long-term GLP-1 use and the weight loss that comes with it

It is, however, a prohibited substance under WADA anti-doping rules (class S2 peptide hormone)

Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study

The Legal and Insurance Fallout For insurers and underwriters, offering compounded GLP1s is a massive red flag

From your initial consultation through ongoing maintenance, we provide the medical expertise and guidance required to succeed in sustainable weight control